| Record Information | 
|---|
| Version | 5.0 | 
|---|
| Status | Detected but not Quantified | 
|---|
| Creation Date | 2021-09-10 23:55:48 UTC | 
|---|
| Update Date | 2021-09-26 22:56:15 UTC | 
|---|
| HMDB ID | HMDB0246907 | 
|---|
| Secondary Accession Numbers | None | 
|---|
| Metabolite Identification | 
|---|
| Common Name | (8S,9S,10R,13S,14S,17R)-11,17-Dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one | 
|---|
| Description | (8S,9S,10R,13S,14S,17R)-11,17-Dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one belongs to the class of organic compounds known as 21-hydroxysteroids. These are steroids carrying a hydroxyl group at the 21-position of the steroid backbone. Based on a literature review very few articles have been published on (8S,9S,10R,13S,14S,17R)-11,17-Dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one. This compound has been identified in human blood as reported by (PMID: 31557052  ). (8s,9s,10r,13s,14s,17r)-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-7,8,9,11,12,14,15,16-octahydro-6h-cyclopenta[a]phenanthren-3-one is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically (8S,9S,10R,13S,14S,17R)-11,17-Dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources. | 
|---|
| Structure | CC12CC(O)C3C(CCC4=CC(=O)C=CC34C)C1CCC2(O)C(=O)COInChI=1S/C21H28O5/c1-19-7-5-13(23)9-12(19)3-4-14-15-6-8-21(26,17(25)11-22)20(15,2)10-16(24)18(14)19/h5,7,9,14-16,18,22,24,26H,3-4,6,8,10-11H2,1-2H3 | 
|---|
| Synonyms | Not Available | 
|---|
| Chemical Formula | C21H28O5 | 
|---|
| Average Molecular Weight | 360.45 | 
|---|
| Monoisotopic Molecular Weight | 360.193674002 | 
|---|
| IUPAC Name | 14,17-dihydroxy-14-(2-hydroxyacetyl)-2,15-dimethyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadeca-3,6-dien-5-one | 
|---|
| Traditional Name | 14,17-dihydroxy-14-(2-hydroxyacetyl)-2,15-dimethyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadeca-3,6-dien-5-one | 
|---|
| CAS Registry Number | Not Available | 
|---|
| SMILES | CC12CC(O)C3C(CCC4=CC(=O)C=CC34C)C1CCC2(O)C(=O)CO | 
|---|
| InChI Identifier | InChI=1S/C21H28O5/c1-19-7-5-13(23)9-12(19)3-4-14-15-6-8-21(26,17(25)11-22)20(15,2)10-16(24)18(14)19/h5,7,9,14-16,18,22,24,26H,3-4,6,8,10-11H2,1-2H3 | 
|---|
| InChI Key | OIGNJSKKLXVSLS-UHFFFAOYSA-N | 
|---|
| Chemical Taxonomy | 
|---|
| Description | Belongs to the class of organic compounds known as 21-hydroxysteroids. These are steroids carrying a hydroxyl group at the 21-position of the steroid backbone. | 
|---|
| Kingdom | Organic compounds | 
|---|
| Super Class | Lipids and lipid-like molecules | 
|---|
| Class | Steroids and steroid derivatives | 
|---|
| Sub Class | Hydroxysteroids | 
|---|
| Direct Parent | 21-hydroxysteroids | 
|---|
| Alternative Parents |  | 
|---|
| Substituents | Progestogin-skeleton21-hydroxysteroid20-oxosteroidPregnane-skeleton3-oxo-delta-1,4-steroid3-oxosteroidOxosteroid11-hydroxysteroid17-hydroxysteroidDelta-1,4-steroidCyclic alcoholTertiary alcoholAlpha-hydroxy ketoneKetoneSecondary alcoholCyclic ketonePrimary alcoholAlcoholHydrocarbon derivativeOrganooxygen compoundOrganic oxideOrganic oxygen compoundCarbonyl groupAliphatic homopolycyclic compound
 | 
|---|
| Molecular Framework | Aliphatic homopolycyclic compounds | 
|---|
| External Descriptors | Not Available | 
|---|
| Ontology | 
|---|
| Physiological effect | Not Available | 
|---|
| Disposition |  | 
|---|
| Process | Not Available | 
|---|
| Role | Not Available | 
|---|
| Physical Properties | 
|---|
| State | Not Available | 
|---|
| Experimental Molecular Properties | | Property | Value | Reference | 
|---|
 | Melting Point | Not Available | Not Available |  | Boiling Point | Not Available | Not Available |  | Water Solubility | Not Available | Not Available |  | LogP | Not Available | Not Available | 
 | 
|---|
| Experimental Chromatographic Properties | Not Available | 
|---|
| Predicted Molecular Properties |  | 
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference | 
|---|
 | Predicted by Siyang on May 30, 2022 | 12.0753 minutes | 33406817 |  | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 1.63 minutes | 32390414 |  | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 2392.9 seconds | 40023050 |  | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 204.0 seconds | 40023050 |  | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 161.6 seconds | 40023050 |  | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 172.2 seconds | 40023050 |  | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 142.0 seconds | 40023050 |  | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 491.4 seconds | 40023050 |  | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 514.1 seconds | 40023050 |  | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 122.3 seconds | 40023050 |  | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 981.4 seconds | 40023050 |  | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 418.8 seconds | 40023050 |  | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 1355.7 seconds | 40023050 |  | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 311.0 seconds | 40023050 |  | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 396.1 seconds | 40023050 |  | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 312.7 seconds | 40023050 |  | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 221.2 seconds | 40023050 |  | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 31.5 seconds | 40023050 | 
 Predicted Kovats Retention IndicesUnderivatized| Metabolite | SMILES | Kovats RI Value | Column Type | Reference | 
|---|
 | (8S,9S,10R,13S,14S,17R)-11,17-Dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one | CC12CC(O)C3C(CCC4=CC(=O)C=CC34C)C1CCC2(O)C(=O)CO | 3580.5 | Standard polar | 33892256 |  | (8S,9S,10R,13S,14S,17R)-11,17-Dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one | CC12CC(O)C3C(CCC4=CC(=O)C=CC34C)C1CCC2(O)C(=O)CO | 2652.7 | Standard non polar | 33892256 |  | (8S,9S,10R,13S,14S,17R)-11,17-Dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one | CC12CC(O)C3C(CCC4=CC(=O)C=CC34C)C1CCC2(O)C(=O)CO | 3312.9 | Semi standard non polar | 33892256 | 
 Derivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference | 
|---|
 | (8S,9S,10R,13S,14S,17R)-11,17-Dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one,4TMS,isomer #1 | CC12C=CC(=O)C=C1CCC1C2C(O[Si](C)(C)C)CC2(C)C1CCC2(O[Si](C)(C)C)C(=CO[Si](C)(C)C)O[Si](C)(C)C | 3238.6 | Semi standard non polar | 33892256 |  | (8S,9S,10R,13S,14S,17R)-11,17-Dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one,4TMS,isomer #1 | CC12C=CC(=O)C=C1CCC1C2C(O[Si](C)(C)C)CC2(C)C1CCC2(O[Si](C)(C)C)C(=CO[Si](C)(C)C)O[Si](C)(C)C | 3205.7 | Standard non polar | 33892256 |  | (8S,9S,10R,13S,14S,17R)-11,17-Dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one,4TMS,isomer #1 | CC12C=CC(=O)C=C1CCC1C2C(O[Si](C)(C)C)CC2(C)C1CCC2(O[Si](C)(C)C)C(=CO[Si](C)(C)C)O[Si](C)(C)C | 3587.7 | Standard polar | 33892256 |  | (8S,9S,10R,13S,14S,17R)-11,17-Dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one,4TBDMS,isomer #1 | CC12C=CC(=O)C=C1CCC1C2C(O[Si](C)(C)C(C)(C)C)CC2(C)C1CCC2(O[Si](C)(C)C(C)(C)C)C(=CO[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C | 4175.5 | Semi standard non polar | 33892256 |  | (8S,9S,10R,13S,14S,17R)-11,17-Dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one,4TBDMS,isomer #1 | CC12C=CC(=O)C=C1CCC1C2C(O[Si](C)(C)C(C)(C)C)CC2(C)C1CCC2(O[Si](C)(C)C(C)(C)C)C(=CO[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C | 4043.6 | Standard non polar | 33892256 |  | (8S,9S,10R,13S,14S,17R)-11,17-Dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one,4TBDMS,isomer #1 | CC12C=CC(=O)C=C1CCC1C2C(O[Si](C)(C)C(C)(C)C)CC2(C)C1CCC2(O[Si](C)(C)C(C)(C)C)C(=CO[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C | 3852.0 | Standard polar | 33892256 | 
 | 
|---|
|  | GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View | 
|---|
 | Predicted GC-MS | Predicted GC-MS Spectrum - (8S,9S,10R,13S,14S,17R)-11,17-Dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one GC-MS (Non-derivatized) - 70eV, Positive | splash10-053r-3955000000-b3c71566be4e1aa0d730 | 2021-09-24 | Wishart Lab | View Spectrum |  | Predicted GC-MS | Predicted GC-MS Spectrum - (8S,9S,10R,13S,14S,17R)-11,17-Dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |  | Predicted GC-MS | Predicted GC-MS Spectrum - (8S,9S,10R,13S,14S,17R)-11,17-Dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one GC-MS (TMS_1_1) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum |  | Predicted GC-MS | Predicted GC-MS Spectrum - (8S,9S,10R,13S,14S,17R)-11,17-Dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one GC-MS (TMS_1_2) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum |  | Predicted GC-MS | Predicted GC-MS Spectrum - (8S,9S,10R,13S,14S,17R)-11,17-Dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one GC-MS (TMS_1_3) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum |  | Predicted GC-MS | Predicted GC-MS Spectrum - (8S,9S,10R,13S,14S,17R)-11,17-Dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one GC-MS (TMS_1_4) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum |  | Predicted GC-MS | Predicted GC-MS Spectrum - (8S,9S,10R,13S,14S,17R)-11,17-Dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one GC-MS (TMS_2_1) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum |  | Predicted GC-MS | Predicted GC-MS Spectrum - (8S,9S,10R,13S,14S,17R)-11,17-Dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one GC-MS (TMS_2_2) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum |  | Predicted GC-MS | Predicted GC-MS Spectrum - (8S,9S,10R,13S,14S,17R)-11,17-Dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one GC-MS (TMS_2_3) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum |  | Predicted GC-MS | Predicted GC-MS Spectrum - (8S,9S,10R,13S,14S,17R)-11,17-Dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one GC-MS (TMS_2_4) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum |  | Predicted GC-MS | Predicted GC-MS Spectrum - (8S,9S,10R,13S,14S,17R)-11,17-Dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one GC-MS (TMS_2_5) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum |  | Predicted GC-MS | Predicted GC-MS Spectrum - (8S,9S,10R,13S,14S,17R)-11,17-Dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one GC-MS (TMS_2_6) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum |  | Predicted GC-MS | Predicted GC-MS Spectrum - (8S,9S,10R,13S,14S,17R)-11,17-Dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one GC-MS (TMS_3_1) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum |  | Predicted GC-MS | Predicted GC-MS Spectrum - (8S,9S,10R,13S,14S,17R)-11,17-Dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one GC-MS (TMS_3_2) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum |  | Predicted GC-MS | Predicted GC-MS Spectrum - (8S,9S,10R,13S,14S,17R)-11,17-Dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one GC-MS (TMS_3_3) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum |  | Predicted GC-MS | Predicted GC-MS Spectrum - (8S,9S,10R,13S,14S,17R)-11,17-Dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one GC-MS (TMS_3_4) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum |  | Predicted GC-MS | Predicted GC-MS Spectrum - (8S,9S,10R,13S,14S,17R)-11,17-Dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one GC-MS (TBDMS_1_1) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum |  | Predicted GC-MS | Predicted GC-MS Spectrum - (8S,9S,10R,13S,14S,17R)-11,17-Dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one GC-MS (TBDMS_1_2) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum |  | Predicted GC-MS | Predicted GC-MS Spectrum - (8S,9S,10R,13S,14S,17R)-11,17-Dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one GC-MS (TBDMS_1_3) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum |  | Predicted GC-MS | Predicted GC-MS Spectrum - (8S,9S,10R,13S,14S,17R)-11,17-Dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one GC-MS (TBDMS_1_4) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum |  | Predicted GC-MS | Predicted GC-MS Spectrum - (8S,9S,10R,13S,14S,17R)-11,17-Dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one GC-MS (TBDMS_2_1) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum |  | Predicted GC-MS | Predicted GC-MS Spectrum - (8S,9S,10R,13S,14S,17R)-11,17-Dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one GC-MS (TBDMS_2_2) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum |  | Predicted GC-MS | Predicted GC-MS Spectrum - (8S,9S,10R,13S,14S,17R)-11,17-Dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one GC-MS (TBDMS_2_3) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum |  | Predicted GC-MS | Predicted GC-MS Spectrum - (8S,9S,10R,13S,14S,17R)-11,17-Dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one GC-MS (TBDMS_2_4) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum |  | Predicted GC-MS | Predicted GC-MS Spectrum - (8S,9S,10R,13S,14S,17R)-11,17-Dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one GC-MS (TBDMS_2_5) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum | 
 MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View | 
|---|
 | Experimental LC-MS/MS | LC-MS/MS Spectrum - (8S,9S,10R,13S,14S,17R)-11,17-Dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one  40V, Positive-QTOF | splash10-00dj-1930000000-74d7c466fd1ed660c9b7 | 2021-09-20 | HMDB team, MONA | View Spectrum |  | Experimental LC-MS/MS | LC-MS/MS Spectrum - (8S,9S,10R,13S,14S,17R)-11,17-Dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one  50V, Positive-QTOF | splash10-05fv-1920000000-2faf14de517556f3aa19 | 2021-09-20 | HMDB team, MONA | View Spectrum |  | Experimental LC-MS/MS | LC-MS/MS Spectrum - (8S,9S,10R,13S,14S,17R)-11,17-Dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one  30V, Positive-QTOF | splash10-00dj-0960000000-50709501482cf8b2d8fe | 2021-09-20 | HMDB team, MONA | View Spectrum |  | Experimental LC-MS/MS | LC-MS/MS Spectrum - (8S,9S,10R,13S,14S,17R)-11,17-Dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one  40V, Positive-QTOF | splash10-00dj-1930000000-27361c47a128a8fe84cb | 2021-09-20 | HMDB team, MONA | View Spectrum |  | Experimental LC-MS/MS | LC-MS/MS Spectrum - (8S,9S,10R,13S,14S,17R)-11,17-Dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one  20V, Positive-QTOF | splash10-00fv-0792000000-27cad482cf078c701bd8 | 2021-09-20 | HMDB team, MONA | View Spectrum |  | Experimental LC-MS/MS | LC-MS/MS Spectrum - (8S,9S,10R,13S,14S,17R)-11,17-Dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one  10V, Positive-QTOF | splash10-01ox-0019000000-5cc482e3ad958dc5d954 | 2021-09-20 | HMDB team, MONA | View Spectrum |  | Experimental LC-MS/MS | LC-MS/MS Spectrum - (8S,9S,10R,13S,14S,17R)-11,17-Dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one  30V, Positive-QTOF | splash10-00dj-0950000000-dc33df1f1bf1a59a5096 | 2021-09-20 | HMDB team, MONA | View Spectrum |  | Experimental LC-MS/MS | LC-MS/MS Spectrum - (8S,9S,10R,13S,14S,17R)-11,17-Dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one  50V, Positive-QTOF | splash10-05fv-1920000000-e01d6f8e73ba71dee511 | 2021-09-20 | HMDB team, MONA | View Spectrum |  | Experimental LC-MS/MS | LC-MS/MS Spectrum - (8S,9S,10R,13S,14S,17R)-11,17-Dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one  50V, Positive-QTOF | splash10-05fv-1920000000-e7eea79f81588159e393 | 2021-09-20 | HMDB team, MONA | View Spectrum |  | Experimental LC-MS/MS | LC-MS/MS Spectrum - (8S,9S,10R,13S,14S,17R)-11,17-Dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one  40V, Positive-QTOF | splash10-00dj-1930000000-0f13a3d0427b42343afd | 2021-09-20 | HMDB team, MONA | View Spectrum |  | Experimental LC-MS/MS | LC-MS/MS Spectrum - (8S,9S,10R,13S,14S,17R)-11,17-Dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one  20V, Positive-QTOF | splash10-00fv-0792000000-1de85a9110e5b44c009e | 2021-09-20 | HMDB team, MONA | View Spectrum |  | Experimental LC-MS/MS | LC-MS/MS Spectrum - (8S,9S,10R,13S,14S,17R)-11,17-Dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one  30V, Positive-QTOF | splash10-00dj-0960000000-761ad6e7197ea3ecb627 | 2021-09-20 | HMDB team, MONA | View Spectrum |  | Experimental LC-MS/MS | LC-MS/MS Spectrum - (8S,9S,10R,13S,14S,17R)-11,17-Dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one  20V, Positive-QTOF | splash10-00fv-0792000000-0878d20cd31a3d46d9cb | 2021-09-20 | HMDB team, MONA | View Spectrum |  | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - (8S,9S,10R,13S,14S,17R)-11,17-Dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one  10V, Positive-QTOF | splash10-03di-0009000000-4177024fe3069b51472b | 2021-10-12 | Wishart Lab | View Spectrum |  | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - (8S,9S,10R,13S,14S,17R)-11,17-Dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one  20V, Positive-QTOF | splash10-03dl-1925000000-04ffaff9335c63c67700 | 2021-10-12 | Wishart Lab | View Spectrum |  | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - (8S,9S,10R,13S,14S,17R)-11,17-Dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one  40V, Positive-QTOF | splash10-0bvu-4891000000-f529d2a27fa7b2fdb418 | 2021-10-12 | Wishart Lab | View Spectrum |  | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - (8S,9S,10R,13S,14S,17R)-11,17-Dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one  10V, Negative-QTOF | splash10-004i-0009000000-0538a78c2a4cb9b1ee74 | 2021-10-12 | Wishart Lab | View Spectrum |  | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - (8S,9S,10R,13S,14S,17R)-11,17-Dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one  20V, Negative-QTOF | splash10-004i-0019000000-3ef805e9fb24f4248359 | 2021-10-12 | Wishart Lab | View Spectrum |  | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - (8S,9S,10R,13S,14S,17R)-11,17-Dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one  40V, Negative-QTOF | splash10-00di-1095000000-db76f28cc9acc7789ed0 | 2021-10-12 | Wishart Lab | View Spectrum | 
 | 
|---|